Avecho Biotechnology Ltd V.AVE

Primary Symbol: AVEFF

Healthcare Biotechnology

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ltd > $0.90 Buy-Out!!

<< Previous

Bullboard Posts

Next >>

Comment by skibum45on Apr 16, 2018 10:43am

116 Views

Post# 27890528

RE:RE:$0.90 Buy-Out!!

Under the terms of the Earnout, subject to certain conditions contained in the Arrangement Agreement, shareholders of Aveda of record as of the effective date of the Transaction (excluding dissenting shareholders) will be entitled to receive a pro rata share of the amount (if any) by which Aveda’s EBITDA for the specified period (being June 1, 2018 to May 31, 2019 (or if the parties to the Arrangement Agreement mutually agree, July 1, 2018 to June 30, 2019)) exceeds $18.0 million. Subject to certain adjustments, the total amount payable is to be calculated by multiplying 2.74737 by the difference of Aveda’s EBITDA during the specified period and $18.0 million, subject to a maximum payment of $0.45 per share and certain adjustments. Any such amount would be payable in cash approximately 14 months from the close of the Transaction.